Because expression of miR‐126 has been reported to parallel that of its host gene EGFL713, we interrogated EGFL7 expression in CLL patient samples before and after ibrutinib therapy. The gene discussed is EGFL7; the disease is B-cell chronic lymphocytic leukemia.